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ASBESTOS AND CAUSATION OF
NON-RESPIRATORY CANCERS:
EVALUATION BY THE INSTITUTE OF
MEDICINE
Jonathan M. Samet, M.D., M.S. ∗
INTRODUCTION
Asbestos refers to several mineral species when they occur
in a fibrous form. 1 The asbestos fibers have useful properties of
weavability, flexibility, and chemical and physical durability. 2
Consequently, asbestos has been widely used in building
materials, friction products, and fire-retarding fabrics. 3 Asbestos
consumption rose across the 20th century, peaking in the 1970s
and then falling in response to a recognition of asbestos-related
heath risks, which ultimately led to bans of asbestos and
substitution with other materials. 4
Many of the millions of workers in the United States and
other countries who have been exposed to asbestos have
developed asbestos-caused diseases, and millions of current and
∗

M.D., M.S., Department of Epidemiology, Johns Hopkins Bloomberg
School of Public Health, Baltimore, Maryland.
1
THE AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE
103 (4th ed. 2000).
2
See James L. Stengel, The Asbestos End-Game, 62 N.Y.U. ANN.
SURV. AM. L 223, 226 (2006).
3
See generally RACHEL MAINES, ASBESTOS AND FIRE: TECHNOLOGICAL
TRADE-OFFS AND THE BODY AT RISK. (2005).
4
Margaret R. Becklake, Asbestos-Related Diseases of the Lung and
Other Organs: Their Epidemiology and Implications for Clinical Practice,
114 AM. REV. RESPIR. DIS. 187-227 (1976).
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former workers are still at risk, particularly of cancer. 5
Thousands of lawsuits on behalf of affected workers have been
filed against companies that processed asbestos and made
asbestos-containing products. 6 The costs of compensating the
claims have led to bankruptcy for many companies, based on the
numbers of claims already filed and anticipated future claims. 7
The ever-increasing number of lawsuits and the costs to industry
and insurers have led to calls for a legislative remedy at the
federal level, but attempts to pass such legislation have been
unsuccessful to date. 8
Asbestos is known to cause both cancer and diseases of the
lung and pleura, the membrane which surrounds the lungs in the
thorax. 9 Sentinel cases of asbestosis, the scarring disorder of the
lungs caused by inhaling asbestos fibers, were reported in the
early 20th century, but asbestos was not widely recognized as
causing cancer until the 1950s and 1960s when epidemiological
and clinical studies linked asbestos exposure to mesothelioma⎯
cancer of the mesothelium (the surface lining the thoracic and
abdominal cavities)⎯and lung cancer. 10 The identification of
asbestos as a carcinogen lagged its pattern of use because the
increased risks for these cancers only become apparent decades
after first exposure. 11 By then, however, asbestos had been
widely used for more than a half century, millions of workers
had been exposed, and asbestos-containing materials were in
place in thousands of public and commercial buildings in the

5

Timothy Driscoll, et al., The Global Burden of Disease Due to
Occupational Carcinogens, 48 AM. J. INDUS. MED. 419-31 (2005).
6
See Stengel, supra note 2, at 230-33.
7
ERIC STALLARD, KENNETH G. MANTON & JOEL E. COHEN,
FORECASTING PRODUCT LIABILITY CLAIMS: EPIDEMIOLOGY AND MODELING IN
THE MANVILLE ASBESTOS CASE (Springer 2004).
8
Id.
9
See Stengel, supra note 2, at 227-31.
10
See generally Becklake, supra note 4.
11
Paolo Boffetta & Leslie T. Stayner, Pleural and Peritoneal
Neoplasms, in CANCER EPIDEMIOLOGY AND PREVENTION 659, 659-73 (David
Schottenfeld & Joseph F. Fraumeni, Jr. 3d ed., Oxford Univ. Press 2006).

SAMET.DOC

7/1/2007 10:46 PM

CAUSATION OF NON-RESPIRATORY CANCERS

1119

United States. 12
Asbestosis refers to the disease caused by diffuse fibrosis
(scarring) of the lung’s interstitium (fibrous skeleton); as the
disease progresses, the lungs contract progressively and
eventually cannot function sufficiently to support respiration. 13
Epidemiological studies of workers show that asbestosis has
been most frequent among those with particularly high exposures
in the past. 14 Asbestos exposure also causes fibrosis and plaque
formation in the pleura, leading to physiological abnormalities
that may impair lung function and pleural effusion, the
accumulation of fluid in the pleural space.15
Inhalation of asbestos fibers also causes cancers of the
respiratory tract, including cancer of the lung and mesothelioma.
In the 1950s, Sir Richard Doll provided the first epidemiological
evidence linking an excess occurrence of lung cancer to asbestos
exposure. 16 This finding has since been confirmed in many
studies among workers and in the general population; however,
uncertainty remains concerning the magnitude of the excess in
non-smokers and the degree of synergism between smoking and
asbestos exposure. 17 In the early 1960s, the South African
pathologist Chris Wagner described malignant mesothelioma and
its association with asbestos exposure. 18 While other risk factors
have been postulated for mesothelioma, most cases are
considered to be caused by asbestos fibers.19
12

Id.
See generally Becklake, supra note 4.
14
Id.
15
LINDA ROSENSTOCK ET AL., TEXTBOOK OF CLINICAL OCCUPATIONAL
AND ENVIRONMENTAL MEDICINE 825, 825-37 (1994).
16
Richard Doll, Mortality from Lung Cancer in Asbestos Workers, 12
BRIT. J. INDUST. MED. 81, 81-86 (1955).
17
See generally International Agency for Research on Cancer, IARC
MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS:
MAN-MADE VITREOUS FIBERS (2002), available at http://monographs.iarc.fr/
ENG/Monographs/vol81/volume81.pdf.
18
J.C. Wagner et al., Diffuse Pleural Mesothelioma and Asbestos
Exposure in the North Western Cape Province, 17 BRIT. J. INDUST. MED.
260, 260-71 (1960).
19
Rosenstock, supra note 15, at 825-37.
13
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Most claims for compensation related to asbestos exposure
have been filed for asbestosis, lung cancer, and malignant
mesothelioma. Anatomic sites other than the lungs and
mesothelial surfaces, however, are exposed to asbestos fibers as
they transit through the upper airway in inhaled air and as fibers
deposited in the lung are cleared via the mucociliary apparatus
to eventually pass through the gastrointestinal tract.
Epidemiological studies have shown associations of asbestos
exposure with cancers of the oropharynx, larynx, esophagus,
stomach, colon, rectum, and ovaries. 20 However, the evidence
for asbestos as a cause of cancers of these sites is less abundant
and less consistent than for lung cancer and mesothelioma. 21
For a number of years, the United States Congress has given
consideration to legislation for a national system to provide
compensation for persons with asbestos-caused disease. 22 In
2005, Senate Bill 852, the Fairness in Asbestos Injury
Resolution (FAIR) Act, proposed an industry-underwritten trust
fund to provide compensation for asbestos-exposed persons as
well as affected people living in Libby, Montana.23 The
language of the bill called for the Institute of Medicine (IOM) to
carry out a study of the evidence on the association of asbestos
with colorectal, laryngeal, oropharyngeal, stomach, and
esophageal cancers. 24 A multidisciplinary committee was
appointed for this purpose, which included members with
expertise
in
epidemiology,
biostatistics,
pathology,
carcinogenesis, oncology, industrial hygiene, and mineralology.
The Committee’s charge was to:
[c]omprehensively review, evaluate, and summarize
the peer-reviewed scientific and medical literature
regarding the association between asbestos and
colorectal, laryngeal, esophageal, pharyngeal, and
20

see generally INSTITUTE OF MEDICINE, ASBESTOS: SELECTED CANCERS
(2006). [Hereinafter: ASBESTOS: SELECTED CANCERS]
21
Id. at Ch. 5.
22
STEPHEN J. CARROLL ET AL., ASBESTOS LITIGATION (2005).
23
Fairness in Asbestos Injury Resolution (FAIR) Act, S. 852 109th
Cong. § 1 (2005).
24
Id.
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stomach cancer. Based on its examination and
evaluation of the extant literature and other
information it may obtain in the course of the study,
the committee will determine if there is a causal
association between asbestos and colorectal,
laryngeal, esophageal, pharyngeal, or stomach
cancers. 25
This paper describes the committee’s approach to addressing
the charge and its findings with regard to whether asbestos is
causally associated with the specified cancers. It then offers
recommendations for future evidence reviews related to
evaluating evidence for causality for the purpose of
compensation.
I. COMMITTEE APPROACH
The committee construed its charge as calling for a
classification of the evidence relevant to each anatomical site
with regard to its strength in supporting a causal relationship. 26
The committee was not asked to address the carcinogenicity of
asbestos fibers, which have long been classified as
carcinogenic. 27 The committee did consider, however, that the
substantial literature on mechanisms of carcinogenesis by
asbestos fibers was relevant to its charge, as were data on the
doses of fibers reaching target cells in the organs of interest. 28
The committee recognized that the epidemiological evidence
would be of particular relevance.
In addressing its charge, the committee considered widely
used approaches for systematically gathering and synthesizing
25

ASBESTOS: SELECTED CANCERS, supra note 20, at 1.
Id. at 20.
27
International Agency for Research on Cancer, IARC MONOGRAPHS
ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS: MAN-MADE
VITREOUS FIBERS (2002) available at http://monographs.iarc.fr/ENG/
Monographs/vol81/volume81.pdf.; NATIONAL TOXICOLOGY PROGRAM (NTP),
ELEVENTH REPORT ON CARCINOGENS, (Department of Health and Human
Services, Public Health Service, 2005).
28
ASBESTOS: SELECTED CANCERS, supra note 20, at 16.
26
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evidence. 29 The committee judged that a full systematic review
was needed that would involve gathering all of the relevant
epidemiological evidence and combing the evidence qualitatively
and quantitatively. Its approach used the evidence synthesis
method generally referred to as “meta-analysis”⎯a replicable
search strategy involving the abstracting of the findings of the
individual investigations, and a quantitative summary of the
results of the studies for the specified sites of cancer. 30
The committee debated whether to present the findings of the
individual studies without estimating a summary measure of risk
or combine the results, yielding a summary measure of the
increased risk for cancer associated with asbestos exposure as
well as a 95 percent confidence interval around the estimate, an
indicator of the degree of statistical uncertainty. Such estimates
are readily derived with standard statistical models and software,
but their interpretation can be complicated by variation in the
characteristics of the studies that are pooled. In a setting of
substantial variability in study populations and methods, an
overall estimate may have uncertain validity and generalizability.
Nonetheless, the committee did calculate summary estimates
while expressing caution in their interpretation and indicating
that the level of statistical significance of the estimates was not a
criterion for their interpretation or for causal inference.
Figures 1 and 2 provide examples of the committee’s metaanalysis. 31 Figure 1 gives the results of risk for laryngeal cancer
from cohort (follow-up) studies of workers. The risks from each
study, comparing “exposed” to a non-exposed comparison group
are given; the circle provides the point estimate of risk and the
line is the length of the 95 percent confidence interval around
the estimate. The line at the bottom gives the pooled result,
which has a narrow confidence interval because information is
29

The IOM itself does not have a formulaic approach to the task of
evidence synthesis, but rather leaves the selection of review methods to
individual committees. See ASBESTOS: SELECTED CANCERS, supra note 20.
30
DIANA B. PETITTI, META-ANALYSIS, DECISION ANALYSIS, AND COSTEFFECTIVENESS ANALYSIS: METHODS FOR QUANTITATIVE SYNTHESIS IN
MEDICINE (Oxford Univ. Press 2d ed. 2000).
31
ASBESTOS: SELECTED CANCERS, supra note 20.
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pooled across studies. The committee also sought evidence for a
dose-response relationship between asbestos exposure and cancer
risk by analyzing the data for the most exposed group in each
study compared to non-exposed (Figure 2).
To meet its charge, the committee needed to establish a
transparent approach for causal inference. In doing so, it
attempted to gather all of the epidemiological findings and to
consider the broad range of other relevant evidence; it applied
criteria for evidence evaluation, and it classified the strength of
evidence for causality using a predetermined and uniform
classification. Its criteria for evidence evaluation were based on
those proposed in the 1964 report of the U.S. Surgeon General
on smoking and health, a landmark report that found smoking to
be a cause of lung cancer. 32 Sir Austin Bradford Hill, a British
medical stistician, had offered a similar set of criteria. 33 The
criteria of the 1964 report included: (1) the consistency of the
association; (2) the strength of the association; (3) the specificity
of the association; (4) the temporal relationship of the
association; and (5) the coherence of the association.
Consistency, as a general matter, refers to the comparability of
findings of studies; consistency of association with replication in
multiple populations by different investigators using different
research methods weighs against bias or other methodological
problems as an explanation for the association. “Strength of
association” refers to the extent to which risk is increased by
exposure, a positive dose-response relationship, i.e., increasing
strength of association with greater exposure to the agent of
interest is one aspect of the strength of association relevant to
causal inference. As the association becomes stronger, bias
becomes a less plausible explanation for an observed association,
particularly if there is a positive dose-response relationship. A
proper temporal relationship between the putative cause and its
32

PUBLIC HEALTH SERVICE, U.S. DEP’T OF HEALTH, EDUC., AND
WELFARE, SMOKING AND HEALTH: REPORT OF THE ADVISORY COMM. TO THE
SURGEON GEN. OF THE PUBLIC HEALTH SERV. (U.S. Government Printing
Office 1964).
33
Austin Bradford Hill, The Environment and Disease: Association or
Causation?, 58 PROC. R. SOC. MED. 295, 295-300 (1965).
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effect is requisite, i.e., exposure must precede the occurrence of
the outcome, rather than be a consequence of it. “Coherence”
refers to the extent to which a causal association is plausible
based in biological understanding of the basis of the association,
and to the extent to which is complementary with other lines of
evidence. “Specificity” refers to a unique exposure-disease
relationship, as is characteristic of diseases caused by infectious
organisms. For cancer, there are few examples of highly specific
associations (the association between asbestos and mesothelioma
being one such example), and this criterion is usually set aside
in evaluating evidence.
To classify the strength of evidence for causation, the
committee selected a four-level hierarchy based on that used by
the 2004 report of the Surgeon General on the adverse
consequences for health of smoking cigarettes (Table 1). 34 The
categories reflect the adequacy of the evidence available and the
degree of certainty with regard to the role of asbestos fibers in
causing cancer of the particular site under evaluation. The first
category, “evidence is sufficient to infer a causal relationship,”
corresponds directly to the committee’s charge, requiring it to
“determine if there is a causal association” between asbestos
exposure and the listed cancers. The category “suggestive”
refers to situations in which evidence is indicative of association
but not sufficient to infer causality. This category would be
considered if the biological plausibility of the association were
uncertain or the epidemiological evidence limited in scope or
inconsistent. With greater limitation of the available evidence,
the category of “inadequate” would be applicable. The category
“suggestive of no causal relationship,” refers to the infrequent
circumstance of having strong evidence that the putative causal
factor is not associated with disease. This category is used
infrequently in causal inference as its application would call for
convincing evidence of no association; i.e., a precise indication
that the factor does not elevate the risk and for having no
34

See generally CENTERS FOR DISEASE CONTROL AND PREVENTION, U.S.
DEPT. OF HEALTH AND HUMAN SERV., THE HEALTH CONSEQUENCES OF
SMOKING: A REPORT OF THE SURGEON GENERAL (U.S. Government Printing
Office 2004).
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biological basis for considering it as a risk factor.
The committee selected this four-level scheme in advance of
reviewing the evidence. While its charge called only for
determination of a causal association with asbestos exposure for
each site, it considered that a standard and accepted
classification scheme should be used and that a two-level
classification should be avoided. The committee also determined
a priori that its review of the evidence would be based in the
long-applied causal guidelines.
The committee chose not to evaluate the evidence in relation
to the major fiber types of asbestos. Although there is evidence
that risk of mesothelioma differs by fiber type (chrysotile versus
amphibole fibers), 35 the committee could not find a strong
biological rationale for stratifying its approach by fiber type and
it anticipated that the evidence would not be abundant by fiber
type for the cancers considered. It also did not attempt to
quantify cancer risk in relation to estimated exposures. Such
quantification might be used for establishing a compensation
scheme, but its development exceeded the committee’s charge.
II. METHODOLOGICAL CONCERNS
The committee’s review and judgments as to the level of
evidence for causality were based largely in the epidemiological
evidence available for the five cancer sites. The epidemiological
findings came from studies of two designs: cohort studies of
workers and case-control studies carried out in the general
population. The cohort study design involves follow-up of
exposed persons and a comparison group of non-exposed
persons with assessment of cancer occurrence in the two groups.
In the case-control study design, past exposures to asbestos are
assessed for persons having the cancer of interest (cases) and for
comparable persons not having the cancer (controls). The
validity of findings from epidemiological studies of asbestos
exposure depends on the accuracy with which asbestos exposure
35

Bruce W.S. Robinson & Richard A. Lake, Advances in Malignant
Mesothelioma, 353 N. ENGL. J. MED. 1591, 1592 (2005).
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can be classified and on the availability of information on other
factors, e.g., cigarette smoking, that may also cause the cancer
and possibly modify the risk of asbestos exposure. In its
assessment of the evidence, the committee carefully considered
these methodological issues.
With regard to exposure classification, the cohort studies
generally involved observation of asbestos worker groups and
comparison of the incidence or mortality rates for the cancer of
interest to rates in a comparison population—for many studies,
the rates in the population in general. Employment in the
asbestos industry is a surrogate for exposure, on the tenable
assumption that workers in an industry involved with asbestos
would have more exposure on average than the general
population or a similar worker group in an industry not involved
with asbestos. Some of the cohort studies also included semiquantitative estimates of the exposures of the workers to asbestos
fibers; generally, these estimates are based on a limited set of
measurements of the concentrations of airborne fibers in
workplaces, extrapolation of the measurements, and expert
judgment of industrial hygienists. These estimates potentially
have a high degree of error, but are useful for exploring doseresponse relationship. Because the error is generally random, it
tends to flatten dose-response relationships, making them more
difficult to detect.
In the case-control studies, a variety of interview-based
approaches have been used to classify exposure to asbestos.
Generally, the study protocols include taking a full occupational
history, covering each job and industry of employment. This
work history information is then matched against a job-exposure
matrix that gives the likelihood of being exposed for a particular
job. 36 In the case-control studies considered by the committee,
36

P.A. Stewart & W.F. Stewart, Occupational Case-Control Studies: II.
Recommendations for Exposure Assessment, 23 AM. J. IND. MED. 313, 31326 (1994). See also, P.A. Stewart et al., A Novel Approach to Data
Collection in a Case-control Study of Cancer and Occupational Exposures, 25
INT’L. J. EPIDEMIOLOGY 744 (1996); P.A. Stewart et al., Questionnaires for
Collecting Detailed Occupational Information for Community-based Casecontrol Studies, 59 AM. IND. HYG. ASSOC. J. 39 (1998).
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there was a range of quality and sophistication in the exposure
classification approaches. Studies in Montreal, for example,
were based on a carefully constructed job-exposure matrix that
was developed by industrial hygienists knowledgeable with
regard to local industry; the interviews of each study participant
were carefully reviewed. 37 Information from a job-exposure
matrix can be used to qualitatively rank exposure profiles of
study participants. At the other extreme, some studies only
crudely inquired as to whether asbestos exposure had occurred.
The information obtained by interview in case-control studies
may be affected by both random and systematic error, as
participants may not remember the details of their work history
or under-report or over-report past exposures. As for cohort
studies, random error reduces the degree of association in casecontrol studies, while systematic error may increase or decrease
associations, depending on the direction of the bias. One
additional source of bias in case-control studies is the reliance on
surrogate respondents in studies of cancers that are rapidly fatal,
such as esophageal cancer. Surrogates, e.g., a surviving spouse
or child, are likely to be less knowledgeable about the work
history of the index study participant.
The committee recognized the potential for error in
classification of asbestos exposure status to affect the results of
the studies that it considered. It developed a pragmatic
classification of the quality of the information available and
stratified some of its analyses by the quality of the exposure
assessment.
For each of the cancers considered, other causal risk factors
have been identified (Table 2). Consequently, the committee
considered whether other factors might have confounded the
association of asbestos exposure with cancer risk, i.e., another
factor spuriously produced the apparent association with
asbestos, and whether other factors modified the association of
asbestos exposure with cancer risk, i.e., whether asbestos and
other factors interacted in a synergistic fashion. The term
37

See e.g., J. SIEMIATYCKI, RISK FACTORS
WORKPLACE (CRC Press 1991).

FOR

CANCER
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“confounding” refers to the situation in a study when the effect
of the exposure under study actually reflects that of another
causal factor. For example, an association between asbestos and
lung cancer would be found in a study if the asbestos-exposed
workers were more likely to be smokers than the non-exposed
workers, even if asbestos were not a cause of lung cancer.
Smoking and alcohol consumption—strong causes of cancers of
the oropharynx, larynx, and esophagus—were of particular
concern as potential confounding factors. Most cohort studies do
not have information available on potential confounding factors;
one strength of the case-control method is that the studies almost
invariably collect information on confounding factors. The
committee evaluated the epidemiological findings and considered
whether uncontrolled confounding could be excluded as a source
of associations observed with asbestos exposure.
“Effect modification” refers to the interdependence of the
effects of two or more factors. 38 For example, there is a
synergistic interdependence (interaction) between smoking and
alcohol consumption in causing cancers of the oropharynx,
larynx, and esophagus; 39 either factor can cause these cancers,
but if both are present the risks are particularly high and exceed
the combined independent effects. For asbestos exposure, there
is a potential for effect modification by other factors,
particularly smoking and alcohol consumption. The existence of
effect modification does not imply that asbestos does not act
independently in causing cancer, but it would produce variation
in asbestos-associated risks across populations as well as having
potential implications for compensation schemes. The
information available on effect modification was limited, coming
primarily from the case-control studies. In its review, the
committee remarked on findings relevant to effect modification.

38

See e.g., K. ROTHMAN & S. GREENLAND, MODERN EPIDEMIOLOGY
(Lippincott-Raven 1998).
39
International Agency for Research on Cancer, TOBACCO SMOKE AND
INVOLUNTARY SMOKING (2002) available at http://monographs.iarc.fr/ENG/
Monographs/vol83/volume83.pdf.
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III. COMMITTEE FINDINGS
Using its uniform approach, the committee worked in teams
to assemble and evaluate the evidence for each of the cancers.
Additionally, in introductory chapters, it reviewed relevant
research findings on the carcinogenicity of asbestos fibers and
on exposure and dose patterns for the target organs. It offered
its summary findings for each cancer in a section labeled
“Evidence Integration and Conclusion” that had the subheadings
of “Evidence Considered,” “Consistency,” “Strength of
Association,” “Coherence,” and “Conclusion.” 40
The committee judged the evidence to be “sufficient” to
infer causality only for cancer of the larynx. For cancers of the
pharynx, stomach, and colon and rectum, the evidence was
found to be “suggestive but not sufficient” while for esophageal
cancer, the evidence was classified as “inadequate.” These
differing designations by the committee reflected variation in the
quality and extent of the evidence available, the strength of
association and indication of a dose-response relationship, and
considerations of plausibility (Table 3).
Laryngeal cancer was the only one for which the committee
judged the evidence to be sufficient to infer causality. That
decision reflected biological plausibility, the consistency of the
epidemiological evidence, the strength of the association and the
presence of a dose-response relationship, and findings from the
case-control studies that weighed against confounding as an
explanation for the observed association. With regard to
coherence, for laryngeal cancer the committee noted that the
epithelium of the larynx is similar to that of the lung and that
inhaled asbestos fibers pass through the larynx and may deposit
there. For the three sites for which the evidence was suggestive,
the epidemiological findings were not as strong, and biological
plausibility was less certain. For esophageal cancer, the evidence
was more limited in scope.

40

224.

ASBESTOS: SELECTED CANCERS, supra note 20, at 169, 175, 198, 211,
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CONCLUSION
This committee was asked to determine if exposure to
asbestos causes five specific cancers. The charge was an element
of a bill for a national compensation scheme; the committee
recognized the potential implications of its findings and the need
for an approach that could withstand criticism. Consequently, it
adopted a transparent and comprehensive methodology and
turned to established models for systematic reviews. It attempted
to identify all relevant epidemiological and animal studies and to
review the substantial body of evidence coming from laboratory
studies of carcinogenesis by asbestos fibers. It utilized
consultants to gain insights into potential mechanisms of
carcinogenesis for the targeted cancers. A less comprehensive
approach might have met with criticism because of potential bias
in the selection of studies for review. To date, serious criticisms
have not been voiced against the report and its conclusions.
The report’s findings have not been part of the
implementation of a compensation scheme because the FAIR Act
was not passed in the 109th session of Congress. Notably, in
presentations of the report to congressional staff, there was
discussion as to the implications of the committee’s category of
“suggestive but not sufficient.” For laryngeal cancer, the
conclusion regarding the causality of association with asbestos
exposure would readily be construed as a rationale for
compensation. For the three cancers with evidence reaching the
level of suggestive, however, a policy judgment would be
needed on whether compensation should be offered in the face
of still uncertain evidence.
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Table 1: Four-level Hierarchy of Causation

Evidence is sufficient to infer a causal relationship.
Evidence is suggestive but not sufficient to infer a causal
relationship.
Evidence is inadequate to infer the presence or absence of a
causal relationship (which encompasses evidence that is sparse,
of poor quality, or conflicting).
Evidence is suggestive of no causal relationship.

Source: CENTERS FOR DISEASE CONTROL AND PREVENTION,
U.S. DEPT. OF HEALTH AND HUMAN SERV., THE HEALTH
CONSEQUENCES OF SMOKING: A REPORT OF THE SURGEON
GENERAL (U.S. Government Printing Office 2004).
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Table 2: Some Causal Risk Factors For the Target Cancers
Cancer
Oropharynx
Larynx
Esophagus
Stomach
Colon/rectum

Causal factors
Smoked and oral tobacco, alcohol
consumption, diet
Smoked tobacco, alcohol consumption
Tobacco use, alcohol consumption
Tobacco use, h. Pylori infection
Family history
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Table 3: Summary of Epidemiologic Evidence Considered By the
Committee
Type of
Evidence
Number of
source
citations 41
n (subcohorts)
Aggregate RR
95% CI
n
Aggregate RRs
95% CIs
Number of
source
citations 42
n
Aggregate RR
95% CI

Type of Cancer Investigated
Pharyngeal

14

Laryngeal

Esophageal

Cohort study populations
29
20

Any Exposure vs. None
16
35
25
1.44
1.40
0.99
(1.04-2.00) (1.19-1.64) (0.78-1.27)
Extreme Exposure vs. None
3
11
7
0.93
2.02-2.57
1.35-1.43
(0.21-4.15) (1.47-4.49) (0.79-2.58)
Case-control study populations
6
18
3

Any Exposure vs. None
4
15
insufficient
data for
1.47
1.43
meta(1.10-1.96) (1.15-1.78)

Stomach

Colorectal

34

31

42
1.17
(1.07-1.28)

41
1.15
(1.01-1.31)

13
1.31-1.33
(0.97-1.79)

13
1.24-1.38
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Figure 1: Cohort Studies RR of Laryngeal Cancer With Any
Exposure
Cohort studies: RR of laryngeal cancer in people with “any”
exposure to asbestos compared with people who report none.
INSTITUTE OF MEDICINE, ASBESTOS: SELECTED CANCERS 177
(2006).
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Figure 2: Cohort Studies RR of Laryngeal Cancer Among
Extreme Exposure
Cohort studies: RRs of laryngeal cancer among people in most
extreme exposure category compared with those with no
exposure. ( • = more than one exposure gradient reported in
citation, so the plot contains both highest and lowest estimates of
risk at most extreme category over all gradients)

